Creso Pharma makes strong progress with global growth and cannabis commercialisation strategyPosted by On

() has experienced strong demand for its premium medicinal cannabis products in 2020, with an increase in purchase orders from partners around the world.

The company is confident that it can continue to benefit from the rapid uptake of medicinal cannabis amongst patients.

A prime example is recent data from the Israeli Medical Cannabis Agency (IMCA) which highlighted a significant recent increase in medicinal cannabis uptake from patients in the country.

The IMCA data (part of Israel’s Ministry of Health) shows that the number of authorised medicinal cannabis patients in Israel has more than doubled over the past two years to over 70,000 per month.

USDA Certified Organic Tinctures and salves

Israel now the world’s biggest importer of medicinal cannabis flower and the rapidly growing Israeli market provides an exciting opportunity for Creso Pharma to leverage existing in-country relationships to accelerate growth.

Israeli expansion plans

The company entered the Israeli market in April 2020, following the receipt…

Original Author Link click here to read complete story..



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.